Quer melhorar o conteúdo da página? Proponha uma alteração.
9,029 new tuberculosis cases in the United States in 2018 — a **0.7%
decrease** from 2017 — and an incidence of 2.8 per 100,000, down 1.3%.
Both are the lowest ever reported. Cases have declined steadily since 1993.
And that is the problem.
The arithmetic of elimination
| 2018 incidence | 2.8 per 100,000 = 28 per million |
| US elimination goal | under 1 case per million |
| Annual decline | ~1% |
**A recent model predicted that the U.S. TB elimination goal will not be
attained in the 21st century without greatly increased investment in
detection and treatment of latent TB infection.**
A 1% annual decline compounds slowly. Getting from 28 per million to under 1
that way takes longer than the century has left, which is why "lowest ever
recorded" and "not on track" are both true.
Why latent infection is the lever
**The rate among non-US-born people was more than 14 times that among
US-born people**, and **non-US-born people accounted for roughly two-thirds of
cases.**
Read that together with the recommendation and the mechanism becomes clear.
Most US TB is not recent transmission inside the country — it is **latent
infection, acquired elsewhere, reactivating years later.** Nothing done to
stop people passing TB to each other in the United States touches that
reservoir.
Which is why every recommendation in this report points at the same place:
identify, test and treat populations at high risk for latent TB infection.
Treating latent infection is the only intervention that empties the reservoir
before it produces a case.
Enhanced surveillance, detection, and treatment is the stated requirement —
with the emphasis on finding infections in people who are not ill, which is
the hardest kind of public health programme to fund and to explain.
Source: Centers for Disease Control and Prevention, MMWR.
Licença: CC0 1.0 (domínio público) · Adaptado de www.cdc.gov
1
0
0
0

Comentários

Leia em seguida





